Blood Screening Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Germany, Canada, UK - Size and Forecast 2024-2028

Blood Screening Market Size 2024-2028

The Blood Screening Market size is estimated to grow by USD 1.13 billion, at a CAGR of 6.78% between 2023 and 2028. Blood screening is an essential process that ensures the safety of the blood supply by diagnosing potential infections or diseases in donated blood. Thus, there is an increasing emphasis on comprehensive and efficient blood screening processes due to the increasing demand for blood transfusions. Additionally, the emergence of advancements in medical treatments surgeries, organ transplants, and trauma care has increased the demand for safe and compatible blood products, fuelling the need for comprehensive blood screening. Furthermore, the increasing prevalence of chronic diseases and medical conditions may need surgeries or treatments with associated blood transfusions. Hence, such factors are positively impacting the market growth.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Dynamics and Customer Landscape

The market is advancing rapidly, driven by innovations in reagents & kits and software technology. Key technologies include nucleic acid tests like real-time PCR and nucleic acid technology, enhancing the detection of respiratory diseases, transfusion-transmissible diseases, and cardiovascular diseases. Enzyme-Linked Immunosorbent Assay (ELISA) and chemiluminescence immunoassay offer precise serology tests, while rapid tests provide quick results. Applications extend to hospital settings, oncology testing, and blood contamination analysis, with specific assays such as the D-Dimer assay addressing hemophilia and diphtheria. BioResponse technologies are instrumental in screening for measles and other infectious diseases. This market is critical for blood screening technology, ensuring effective monitoring and management of health conditions. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Significant Market Trends

A key factor shaping the market growth is the automation of the blood screening process. There is a significant transformation in the process due to the advent of automation such that it has enhanced efficiency, accuracy, and overall laboratory operations. Automated systems and robotics play a major role in different stages of the its process, from sample processing to result analysis.

Moreover, the emergence of digital solutions for data management and integration is significantly contributing to enhancing the process. Some of these digital solutions include electronic health records, laboratory information systems, and data analytics for more efficient operations. Hence, such factors are positively impacting the market which in turn will drive the market growth during the forecast period.

Major Market Challenges

High costs associated with the blood screening process are one of the key challenges hindering market growth. The process is essential for ensuring the safety of blood transfusions, but the cost associated with acquiring, implementing, and maintaining advanced screening technologies can pose a significant threat to healthcare systems and blood banks. In addition, the cost of reagents, kits, and consumables used in blood screening adds to the overall cost, especially for high-throughput screening processes. 

Moreover, the initial cost can include state-of-the-art screening technologies comprising expensive equipment, instruments, and robotic systems. Furthermore, additional resources are required to maintain quality control standards, especially for r validation, monitoring, and compliance with regulatory guidelines which adds to the total costs. Hence, such factors are negatively impacting the market which in turn will hinder the market growth during the forecast period.

Buy Now Full Report and Discover More

Market Customer Landscape

The market report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.

 Customer Landscape

Market Segmentation

By Component 

The reagents and kits segment is estimated to witness significant growth during the forecast period. The reagents and kits segment is one of the crucial segments used in the laboratory testing process in order to screen donated blood for infectious diseases and ensure its safety for transfusion. Reagents can be referred to as substances or compounds utilized in laboratory tests to generate a chemical reaction with specific components in a sample, such as blood.

Get a glance at the market contribution of various segments View a PDF Sample

The reagents and kits segment was the largest segment and was valued at USD 1.60 billion in 2018. There is an increasing adoption of reagents in blood screening to detect the presence of antibodies, antigens, or other markers associated with infectious diseases. This segment is a crucial part of the testing process and is selected depending on its specificity, sensitivity, and reliability in detecting specific pathogens. The process plays a major role in ensuring that donated blood is free from infectious diseases, including HIV, hepatitis B and C, syphilis, and other pathogens. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.

By End-user 

Blood banks need to ensure that donated blood is safe from infectious diseases, including HIV, hepatitis B and C, and other pathogens. the main purpose of screening is that it helps to identify and discard potentially contaminated units. There is an increasing need for blood for different medical procedures, such as surgeries, trauma care, cancer treatments, and more. Therefore, it is important to have proper screening which minimizes the risk of complications from transfusions. There is an increasing demand in order to prevent the spread of these diseases through transfusions due to outbreaks of infectious diseases or emerging health threats. Hence, such factors are fuelling the growth of this segment, which in turn will drive the market growth during the forecast period.

By Region

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period.  One of the main factors that is significantly contributing to the growth of the market in North America is due to the growing popularity of blood screening reflects the increasing recognition of its importance in ensuring the safety of the blood supply and preventing the transmission of infectious diseases. The process mainly comprises testing donated blood for different pathogens and health conditions before it is used for medical treatments. Factors such as advancements in medical technology, increased awareness of blood safety, regulatory requirements, and healthcare needs are fuelling the blood screening demand in North America. Hence, such factors are expected to drive the market growth in the region during the forecast period.

Buy Now Full Report and Discover More

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

BCAL Diagnostics Ltd: The company offers blood screening tests such as the BCAL test which is a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring.

• Apollo Hospitals Enterprise Ltd.
• Aster Clinical Lab LLP
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• Dr Lal PathLabs Ltd.
• Eurofins Scientific SE
• F. Hoffmann La Roche Ltd.
• Grifols SA
• Harley Street Health Checks UK Ltd.
• Hemogenomics Pvt. Ltd.
• Laboratory Corp. of America Holdings
• Mankind Pharma Ltd.
• Metropolis Healthcare Ltd.
• QuidelOrtho Corp.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Segment Overview

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.

• Component Outlook 
  • Reagents and kits
  • Instruments
  • Software and services
• End-user Outlook 
  • Blood bank
  • Hospitals
• Geography Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of the World
    • Australia
    • Argentina
    • Brazil

You may also interested in below market reports:

• Bilirubin Blood Test Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, France, China - Size and Forecast 
• Blood Market Analysis North America, Asia, Europe, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast
• RFID Blood Refrigerator and Freezer Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, Canada, China, UK - Size and Forecast 

Market Analyst Overview 

The market is at the forefront of ensuring the safety and efficacy of blood transfusions. Advanced techniques like Ligase chain reaction and Transcription-mediated amplification enable accurate detection of pathogens such as Hepatitis C and Human T-lymphotropic virus (HTLV), crucial in preventing transfusion transmitted diseases. With 1 in 100 children affected by sex development disorders, precise screening methods become imperative. Blood donations rely on technology advancements like NAT technology and Immunoassay to ensure compatibility and safety. However, challenges such as regulatory hurdles, global recession, and inflation impact healthcare budgets and the availability of kits and reagents. Continuous innovation and WHO updates drive the evolution of this vital healthcare sector.

In addition, the market encompasses various segments aimed at ensuring the safety and health of blood products and recipients. Techniques like Nucleic acid amplification tests (NAT), ELISA, CLIA, and EIA play crucial roles in detecting viruses such as HBV and HCV, ensuring the absence of infectious agents in red blood cells and whole blood. Advancements in Reagent & Kits, such as nucleic acid test and rapid test, alongside innovations in computerized immunoassays and next generation sequencing, are significantly enhancing diagnostic capabilities for conditions like sexually transmitted diseases, and ventilator-acquired pneumonia, with techniques including Western blot assays, molecular tests, and polymerase chain reaction (PCR) offering detailed analysis of ribosomal ribonucleic acid and other biomarkers.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2024 and 2028
• Precise estimation of the size of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch